CoChat
Sign Up
Cited by 2Chronic Kidney Disease and DiabetesRenal Diseases and GlomerulopathiesBlood Pressure and Hypertension Studies

Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231

Open access
Weil, E. Jennifer, Fufaa, Gudeta, Jones, Lois I., Lovato, Tracy, Lemley, Kevin V., Hanson, Robert L., Knowler, William C., Bennett, Peter H. +3 more·2018·Diabetes
DOI 10.2337/db18-er03aPMC PMC5828456
Open this paper in CoChat — free account

Abstract

In the above-mentioned article, the mean change in measured glomerular filtration rate (GFR) after 1 month of treatment with losartan was erroneously reported in units of mL/min but should have been …

Integrity signals

Registry

Crossref · 10.2337/db18-er03a

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two long-term, double-blind studies demonstrated no kidney-protective effect of either ACE inhibitors or ARBs among people with type 1 and type 2 diabetes who were normotensive with or without high albuminuria.

    “Moreover, two long-term, double-blind studies demonstrated no kidney-protective effect of either ACE inhibitors or ARBs among people with type 1 and type 2 diabetes who were normotensive with or without high albuminuria (formerly microalbuminuria, 30-299 mg/g creatinine) (79,80).”

    From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [80]

The citation lists haven’t been fetched yet

Cited by 2

Authors
Weil, E. J., Fufaa, G., Jones, L. I., Lovato, T., Lemley, K. V., Hanson, R. L., Knowler, W. C., Bennett, P. H., Yee, B., Myers, B. D., & Nelson, R. G.
ORCID
Venue
Diabetes
Publisher
American Diabetes Association
Published
2018-01-05
Volume
67
Issue
3
Pages
532.1-532
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
DOI
10.2337/db18-er03a
PMC
PMC5828456
OpenAlex
W2782202016
Cited by
2
References
0
Citations by year
2025: 1 · 2022: 1
Type
journal article
Language
en
Open access
Licence
www.diabetesjournals.org/site/license (vor, 239 d)
Locations
  • Diabetes (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
losartan, diabetic nephropathy, type 2 diabetes, Native Americans, glomerular filtration rate, renal protection, angiotensin receptor blockers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review